Breanna Nicole Cook, MHR, LPC-C Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 109 N Fairland St, Pryor, OK 74361 Phone: 918-825-1401 Fax: 918-825-1406 |
Jacqueline Marie Flynn Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 231 E Graham Ave, Pryor, OK 74361 Phone: 918-825-1405 |
Ladena Carol Moore, LPC NCC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 212 S E 1st, Pryor, OK 74361 Phone: 918-825-4115 Fax: 918-825-6612 |
Mrs. Kara Jamison, LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 109 N Fairland St, Pryor, OK 74361 Phone: 918-825-1405 |
Courtney Shiann Anderson, BHP Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 109 N Fairland St, Pryor, OK 74361 Phone: 918-825-1405 Fax: 918-825-1406 |
Janette Marie Nuspl, LPC, NCC Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 231 E Graham Ave, Pryor, OK 74361 Phone: 918-825-1405 |
Anita K Sanders, LADC, BHP Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 212 Se 1st, Pryor, OK 74361 Phone: 918-825-4115 |
Nancy Effner Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 231 E Graham, Pryor, OK 74361 Phone: 918-825-1405 |
Laura Long Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 231 E Graham Ave, Pryor, OK 74361 Phone: 918-825-1405 Fax: 918-825-1406 |
Mrs. Kristine Denise Brinlee, LPC Counselor Medicare: Medicare Enrolled Practice Location: 231 E Graham Ave, Pryor, OK 74361 Phone: 918-825-1405 Fax: 918-825-1406 |
Angela Smith Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 231 E Graham Ave, Pryor, OK 74361 Phone: 918-825-1405 Fax: 918-825-1406 |
Alison Cornelius Peterson, LPC-C Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 109 N Fairland, Pryor, OK 74361 Phone: 918-825-1406 |
Tracy Ternes Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 231 E Graham, Pryor, OK 74361 Phone: 918-825-1405 |
Ms. Donna Latrice Holden Counselor Medicare: Not Enrolled in Medicare Practice Location: 231 E Graham Ave, Pryor, OK 74361 Phone: 918-825-1405 Fax: 918-525-1406 |
Amy Phelps, MS, LPC U/S Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 231 E Graham Ave, Pryor, OK 74361 Phone: 918-825-1405 Fax: 918-825-1406 |
Carol Steinbach, LADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 212 Se 1st, Pryor, OK 74361 Phone: 918-825-4115 Fax: 918-825-6612 |
Tracie Stone Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 205 S Adair St, Pryor, OK 74361 Phone: 918-825-4872 Fax: 918-825-4873 |
Melissa Garrett Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 231 East Graham, Pryor, OK 74361 Phone: 918-825-1405 Fax: 918-825-1406 |
Mrs. Charrie Danielle Hayward Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 215 N. Fairland, Pryor, OK 74361 Phone: 918-825-5810 |
Amy Beth Silas, MS, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 729 N 427, Pryor, OK 74361 Phone: 918-864-2899 Fax: 918-825-2234 |
News Archive
...says an expert in the British Medical Journal. Given the iconic status of hospitals in the eyes of the public, government risks huge unpopularity in dealing with the consequences.
Meda announced today positive results from a Phase III clinical trial of Dymista, a novel formulation of azelastine hydrochloride and fluticasone propionate, in patients with seasonal allergic rhinitis.
Treating maternal psychiatric disorder with commonly used antidepressants is associated with a lower risk of certain pregnancy complications including preterm birth and delivery by Caesarean section, according to researchers at Columbia University's Mailman School of Public Health, Columbia University Medical Center, and the New York State Psychiatric Institute. However, the medications - selective serotonin reuptake inhibitors, or SSRIs - resulted in an increased risk of neonatal problems.
IDM Pharma, Inc. has announced that it has recently met with the U.S. Food and Drug Administration (FDA) and informed the FDA that the Company intends to take immediate action to supplement the data in its current New Drug Application (NDA) for mifamurtide (L-MTP-PE), formerly known as Junovan, which is being reviewed for the treatment of children and adolescents with non-metastatic osteosarcoma.
› Verified 5 days ago